Hepatitis D: Clinical Trials

2 trials for Hepatitis D, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Terminated 2

Follow Hepatitis D: new trials by email Literature Review of Hepatitis D trials Research Report on Hepatitis D

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Safety and Efficacy of ATI-2173 in Combination With Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B Virus Infection and in Subjects With Hepatitis D Virus Coinfection
ATI-2173, Viread, AB-729 - Hepatitis B, Chronic, Hepatitis D
Phase 2TerminatedAntios Therapeutics, Inc402021-03-302022-11-18
Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV)
ARC-520, entecavir, pegylated interferon alpha 2a - Hepatitis B, Hepatitis D
Phase 2TerminatedArrowhead Pharmaceuticals792015-12-012026-01-13

Narrower conditions

Hepatitis B (1)  ·  Hepatitis B, Chronic (1)

Broader conditions

Blood-Borne Infections (2)  ·  Communicable Diseases (2)  ·  DNA Virus Infections (2)  ·  Digestive System Diseases (2)  ·  Hepadnaviridae Infections (2)  ·  Hepatitis (2)  ·  Hepatitis, Viral, Human (2)  ·  Infections (2)  ·  Liver Diseases (2)  ·  RNA Virus Infections (2)  ·  Virus Diseases (2)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Hepatitis B (1)  ·  Hepatitis, Chronic (1)

Interventions

Tenofovir (2)  ·  ARC-520 (1)  ·  Histamine Antagonists (1)  ·  entecavir (1)  ·  peginterferon alfa-2a (1)

Sponsors

Antios Therapeutics, Inc (1)  ·  Arrowhead Pharmaceuticals (1)

Countries

Moldova (2)  ·  Australia (1)  ·  Bulgaria (1)  ·  China (1)  ·  New Zealand (1)  ·  South Korea (1)  ·  Taiwan (1)  ·  Thailand (1)  ·  Ukraine (1)

NIH funding

2015 (1)